These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 31449663)
1. Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome. Kuypers DRJ Clin Pharmacol Ther; 2020 Feb; 107(2):347-358. PubMed ID: 31449663 [TBL] [Abstract][Full Text] [Related]
2. Tacrolimus Intrapatient Variability on Graft Outcomes in Adherent Renal Transplantation Patients: A Cross-Sectional Study. Nafar M; Keshtkari S; Ziaie S; Firouzan A; Borumandnia N; Dalili N; Poorrezagholi F; Samadian F; Samavat S Iran J Kidney Dis; 2024 May; 18(3):187-194. PubMed ID: 38904339 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation. Gonzales HM; McGillicuddy JW; Rohan V; Chandler JL; Nadig SN; Dubay DA; Taber DJ Am J Transplant; 2020 Aug; 20(8):1969-1983. PubMed ID: 32406604 [TBL] [Abstract][Full Text] [Related]
4. Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients. Taber DJ; Hirsch J; Keys A; Su Z; McGillicuddy JW Ther Drug Monit; 2021 Jun; 43(3):401-407. PubMed ID: 33560095 [TBL] [Abstract][Full Text] [Related]
5. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure. Shuker N; Cadogan M; van Gelder T; Roodnat JI; Kho MM; Weimar W; Hesselink DA Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255 [TBL] [Abstract][Full Text] [Related]
6. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. Shuker N; van Gelder T; Hesselink DA Transplant Rev (Orlando); 2015 Apr; 29(2):78-84. PubMed ID: 25687818 [TBL] [Abstract][Full Text] [Related]
7. Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients. Abu Bakar K; Mohamad NA; Hodi Z; McCulloch T; Williams A; Christian M; Key T; Kim JJ Pediatr Nephrol; 2019 Dec; 34(12):2557-2562. PubMed ID: 31520127 [TBL] [Abstract][Full Text] [Related]
8. LCP-Tacrolimus Extended-Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients. Bae EK; Chandran MM; Everitt MD; Benz E; Bock M Clin Transplant; 2024 Aug; 38(8):e15417. PubMed ID: 39087462 [TBL] [Abstract][Full Text] [Related]
9. Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies. Davis S; Gralla J; Klem P; Stites E; Wiseman A; Cooper JE Transplantation; 2020 Apr; 104(4):881-887. PubMed ID: 32224815 [TBL] [Abstract][Full Text] [Related]
10. No Apparent Influence of Nonadherence on Tacrolimus Intrapatient Variability in Stable Kidney Transplant Recipients. Gokoel SRM; Zwart TC; Moes DJAR; van der Boog PJM; de Fijter JW Ther Drug Monit; 2020 Oct; 42(5):702-709. PubMed ID: 32941396 [TBL] [Abstract][Full Text] [Related]
11. Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation. Park Y; Lee H; Eum SH; Kim HD; Ko EJ; Yang CW; Chung BH Front Immunol; 2021; 12():746013. PubMed ID: 34659243 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation. Xie W; Fan S; Liu R; Yan W; Su C; Zheng K; Wang X; Wang Z Transplant Rev (Orlando); 2024 Jul; 38(3):100842. PubMed ID: 38537484 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Staatz CE; Tett SE Clin Pharmacokinet; 2004; 43(10):623-53. PubMed ID: 15244495 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation. David-Neto E; Romano P; Kamada Triboni AH; Ramos F; Agena F; Almeida Rezende Ebner P; Altona M; Galante NZ; Brambate Carvalhinho Lemos F Transplantation; 2017 Jun; 101(6):1365-1372. PubMed ID: 27482958 [TBL] [Abstract][Full Text] [Related]
15. Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection. Sablik KA; Clahsen-van Groningen MC; Hesselink DA; van Gelder T; Betjes MGH PLoS One; 2018; 13(5):e0196552. PubMed ID: 29746495 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. Andrews LM; Li Y; De Winter BCM; Shi YY; Baan CC; Van Gelder T; Hesselink DA Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1225-1236. PubMed ID: 29084469 [TBL] [Abstract][Full Text] [Related]
17. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831 [TBL] [Abstract][Full Text] [Related]
18. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective. Schumacher L; Leino AD; Park JM Pharmacotherapy; 2021 Jan; 41(1):103-118. PubMed ID: 33131078 [TBL] [Abstract][Full Text] [Related]